Endocan and Lumican in Relation to Cardiometabolic Risk in a Pediatric Overweight and Obese Cohort: A Cross-Sectional Study.

Biomed Res Int · 2020 · PMC7448251 · PMID 32879879

Europe PMC DOI

hedged sentence

0.1120

closest p · 2.2× alpha

0.1120

boldest claim

The sentences

did not reach statistical significancep = 0.112not close (p > 0.1)

Patients that fulfilled HDL cholesterol level criterion, impaired fasting glucose, and hypertension had a tendency for lower Endocan levels, although did not reach statistical significance ( p = 0.112, p = 0.087, respectively, p = 0.097, Mann-Whitney U tests).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.